Creative Medical Technology Holdings, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Creative Medical Technology Holdings, Inc. (CELZ) reported Net Income (Loss) Attributable to Noncontrolling Interest of $726 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $726.00.
- Creative Medical Technology Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $1.36K.
- Creative Medical Technology Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $0.00.
- Creative Medical Technology Holdings, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $0.00.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|
| 2026-06-30 | $726.00 10-Q · filed 2026-08-07 | $2.09K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.36K 10-Q · filed 2026-05-08 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-03-20 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |